Annual D&A
$3.74 M
+$1.32 M+54.46%
31 December 2023
Summary:
CASI Pharmaceuticals annual depreciation & amortization is currently $3.74 million, with the most recent change of +$1.32 million (+54.46%) on 31 December 2023. During the last 3 years, it has risen by +$1.93 million (+106.12%). CASI annual D&A is now at all-time high.CASI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
N/A
01 September 2024
Summary:
CASI Pharmaceuticals quarterly depreciation & amortization is not available.CASI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
N/A
01 September 2024
Summary:
CASI Pharmaceuticals TTM depreciation & amortization is not available.CASI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +106.1% | - | - |
5 y5 years | +73.8% | - | - |
CASI Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +106.1% | ||||
5 y | 5 years | at high | +106.1% | ||||
alltime | all time | at high | +580.2% |
CASI Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $3.74 M(+54.5%) | - | - |
Dec 2022 | $2.42 M(+33.4%) | $890.00 K(+16.3%) | $2.42 M(+24.5%) |
Sept 2022 | - | $765.00 K(+129.0%) | $1.95 M(+21.5%) |
June 2022 | - | $334.00 K(-22.9%) | $1.60 M(-7.6%) |
Mar 2022 | - | $433.00 K(+4.8%) | $1.73 M(-4.6%) |
Dec 2021 | $1.81 M(-7.4%) | $413.00 K(-1.9%) | $1.81 M(-3.3%) |
Sept 2021 | - | $421.00 K(-9.5%) | $1.88 M(-1.3%) |
June 2021 | - | $465.00 K(-9.9%) | $1.90 M(-2.6%) |
Mar 2021 | - | $516.00 K(+8.6%) | $1.95 M(-0.4%) |
Dec 2020 | $1.96 M(-9.0%) | $475.00 K(+6.7%) | $1.96 M(+3.4%) |
Sept 2020 | - | $445.00 K(-13.8%) | $1.89 M(+5.6%) |
June 2020 | - | $516.00 K(-1.3%) | $1.79 M(-16.6%) |
Mar 2020 | - | $523.00 K(+27.6%) | $2.15 M(-0.1%) |
Dec 2019 | $2.15 M(+28.8%) | $410.00 K(+19.2%) | $2.15 M(-3.0%) |
Sept 2019 | - | $344.00 K(-60.6%) | $2.22 M(-4.8%) |
June 2019 | - | $873.00 K(+66.0%) | $2.33 M(+23.9%) |
Mar 2019 | - | $526.00 K(+10.5%) | $1.88 M(+12.6%) |
Dec 2018 | $1.67 M(+1318.5%) | $476.00 K(+4.4%) | $1.67 M(+34.4%) |
Sept 2018 | - | $455.90 K(+7.8%) | $1.24 M(+51.8%) |
June 2018 | - | $423.10 K(+33.9%) | $819.00 K(+97.2%) |
Mar 2018 | - | $316.00 K(+552.9%) | $415.30 K(+252.5%) |
Dec 2017 | $117.80 K(+77.1%) | $48.40 K(+53.7%) | $117.80 K(+34.0%) |
Sept 2017 | - | $31.50 K(+62.4%) | $87.90 K(+22.3%) |
June 2017 | - | $19.40 K(+4.9%) | $71.90 K(+8.9%) |
Mar 2017 | - | $18.50 K(0.0%) | $66.00 K(-0.8%) |
Dec 2016 | $66.50 K(-2.8%) | $18.50 K(+19.4%) | $66.50 K(+1.4%) |
Sept 2016 | - | $15.50 K(+14.8%) | $65.60 K(-3.0%) |
June 2016 | - | $13.50 K(-28.9%) | $67.60 K(-4.5%) |
Mar 2016 | - | $19.00 K(+8.0%) | $70.80 K(+3.7%) |
Dec 2015 | $68.40 K(+41.9%) | $17.60 K(+0.6%) | $68.30 K(+3.2%) |
Sept 2015 | - | $17.50 K(+4.8%) | $66.20 K(+6.4%) |
June 2015 | - | $16.70 K(+1.2%) | $62.20 K(+7.1%) |
Mar 2015 | - | $16.50 K(+6.5%) | $58.10 K(+20.8%) |
Dec 2014 | $48.20 K(+177.0%) | $15.50 K(+14.8%) | $48.10 K(+29.6%) |
Sept 2014 | - | $13.50 K(+7.1%) | $37.10 K(+34.9%) |
June 2014 | - | $12.60 K(+93.8%) | $27.50 K(+42.5%) |
Mar 2014 | - | $6500.00(+44.4%) | $19.30 K(+10.3%) |
Dec 2013 | $17.40 K(-15.1%) | $4500.00(+15.4%) | $17.50 K(-4.4%) |
Sept 2013 | - | $3900.00(-11.4%) | $18.30 K(-9.0%) |
June 2013 | - | $4400.00(-6.4%) | $20.10 K(-3.4%) |
Mar 2013 | - | $4700.00(-11.3%) | $20.80 K(+2.5%) |
Dec 2012 | $20.50 K(-46.2%) | $5300.00(-7.0%) | $20.30 K(+4.1%) |
Sept 2012 | - | $5700.00(+11.8%) | $19.50 K(-17.4%) |
June 2012 | - | $5100.00(+21.4%) | $23.60 K(-21.9%) |
Mar 2012 | - | $4200.00(-6.7%) | $30.20 K(-20.7%) |
Dec 2011 | $38.10 K(-45.9%) | $4500.00(-54.1%) | $38.10 K(-21.4%) |
Sept 2011 | - | $9800.00(-16.2%) | $48.50 K(-12.8%) |
June 2011 | - | $11.70 K(-3.3%) | $55.60 K(-11.6%) |
Mar 2011 | - | $12.10 K(-18.8%) | $62.90 K(-10.7%) |
Dec 2010 | $70.40 K(-26.0%) | $14.90 K(-11.8%) | $70.40 K(-6.3%) |
Sept 2010 | - | $16.90 K(-11.1%) | $75.10 K(+10.4%) |
June 2010 | - | $19.00 K(-3.1%) | $68.00 K(-14.2%) |
Mar 2010 | - | $19.60 K(0.0%) | $79.30 K(-16.6%) |
Dec 2009 | $95.10 K | $19.60 K(+100.0%) | $95.10 K(-86.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2009 | - | $9800.00(-67.7%) | $684.00 K(+4.4%) |
June 2009 | - | $30.30 K(-14.4%) | $655.30 K(+22.8%) |
Mar 2009 | - | $35.40 K(-94.2%) | $533.60 K(+67.1%) |
Dec 2008 | $319.20 K(-141.0%) | $608.50 K(-3319.6%) | $319.30 K(-178.5%) |
Sept 2008 | - | -$18.90 K(-79.3%) | -$406.50 K(-18.9%) |
June 2008 | - | -$91.40 K(-48.9%) | -$501.20 K(-22.8%) |
Mar 2008 | - | -$178.90 K(+52.5%) | -$649.20 K(-16.7%) |
Dec 2007 | -$779.10 K(+66.1%) | -$117.30 K(+3.3%) | -$779.10 K(+3.7%) |
Sept 2007 | - | -$113.60 K(-52.5%) | -$751.00 K(-42.1%) |
June 2007 | - | -$239.40 K(-22.5%) | -$1.30 M(+37.6%) |
Mar 2007 | - | -$308.80 K(+246.2%) | -$943.10 K(+101.0%) |
Dec 2006 | -$469.10 K(-402.6%) | -$89.20 K(-86.5%) | -$469.20 K(-20.9%) |
Sept 2006 | - | -$660.20 K(-673.6%) | -$593.20 K(-422.7%) |
June 2006 | - | $115.10 K(-30.3%) | $183.80 K(-4.4%) |
Mar 2006 | - | $165.10 K(-177.4%) | $192.30 K(+24.1%) |
Dec 2005 | $155.00 K(-80.0%) | -$213.20 K(-282.5%) | $155.00 K(-69.6%) |
Sept 2005 | - | $116.80 K(-5.5%) | $509.10 K(-11.8%) |
June 2005 | - | $123.60 K(-3.3%) | $577.00 K(-11.6%) |
Mar 2005 | - | $127.80 K(-9.3%) | $652.70 K(-15.6%) |
Dec 2004 | $773.80 K(-16.9%) | $140.90 K(-23.7%) | $773.70 K(+55.1%) |
Sept 2004 | - | $184.70 K(-7.3%) | $499.00 K(-25.3%) |
June 2004 | - | $199.30 K(-19.9%) | $668.30 K(-18.9%) |
Mar 2004 | - | $248.80 K(-285.9%) | $824.50 K(-11.4%) |
Dec 2003 | $930.80 K(-38.3%) | -$133.80 K(-137.8%) | $930.70 K(-35.7%) |
Sept 2003 | - | $354.00 K(-0.4%) | $1.45 M(-1.9%) |
June 2003 | - | $355.50 K(+0.1%) | $1.48 M(-1.3%) |
Mar 2003 | - | $355.00 K(-7.4%) | $1.50 M(-0.8%) |
Dec 2002 | $1.51 M(+9.6%) | $383.50 K(+0.2%) | $1.51 M(+1.6%) |
Sept 2002 | - | $382.60 K(+1.8%) | $1.49 M(+2.0%) |
June 2002 | - | $375.70 K(+2.4%) | $1.46 M(+2.0%) |
Mar 2002 | - | $366.80 K(+1.9%) | $1.43 M(+3.7%) |
Dec 2001 | $1.38 M(+27.7%) | $360.10 K(+2.1%) | $1.38 M(+4.1%) |
Sept 2001 | - | $352.80 K(+1.8%) | $1.32 M(+6.3%) |
June 2001 | - | $346.70 K(+9.5%) | $1.24 M(+8.0%) |
Mar 2001 | - | $316.50 K(+3.3%) | $1.15 M(+6.9%) |
Dec 2000 | $1.08 M(+19.7%) | $306.30 K(+11.4%) | $1.08 M(+10.9%) |
Sept 2000 | - | $275.00 K(+8.2%) | $971.50 K(+3.5%) |
June 2000 | - | $254.20 K(+4.9%) | $939.00 K(+6.4%) |
Mar 2000 | - | $242.30 K(+21.1%) | $882.70 K(-1.9%) |
Dec 1999 | $900.00 K(+28.6%) | $200.00 K(-17.5%) | $900.00 K(+12.5%) |
Sept 1999 | - | $242.50 K(+22.5%) | $800.00 K(+5.6%) |
June 1999 | - | $197.90 K(-23.8%) | $757.50 K(-0.3%) |
Mar 1999 | - | $259.60 K(+159.6%) | $759.60 K(+8.5%) |
Dec 1998 | $700.00 K(+133.3%) | $100.00 K(-50.0%) | $700.00 K(0.0%) |
Sept 1998 | - | $200.00 K(0.0%) | $700.00 K(+16.7%) |
June 1998 | - | $200.00 K(0.0%) | $600.00 K(+50.0%) |
Mar 1998 | - | $200.00 K(+100.0%) | $400.00 K(+33.3%) |
Dec 1997 | $300.00 K(+50.0%) | $100.00 K(0.0%) | $300.00 K(+50.0%) |
Sept 1997 | - | $100.00 K(>+9900.0%) | $200.00 K(0.0%) |
June 1997 | - | $0.00(-100.0%) | $200.00 K(-33.3%) |
Mar 1997 | - | $100.00 K(>+9900.0%) | $300.00 K(+50.0%) |
Dec 1996 | $200.00 K | $0.00(-100.0%) | $200.00 K(0.0%) |
Sept 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
June 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is CASI Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for CASI Pharmaceuticals?
- What is the all time high quarterly D&A for CASI Pharmaceuticals?
- What is the all time high TTM D&A for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CASI is $3.74 M
What is the all time high annual D&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual depreciation & amortization is $3.74 M
What is the all time high quarterly D&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly depreciation & amortization is $890.00 K
What is the all time high TTM D&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM depreciation & amortization is $2.42 M